Company

1.

About Us

"Introduction to HeimBiotek"

Advancing the Future of

Molecular Diagnostics

    To uphold its commitment to excellence embodied in its motto to be “The First or The Best”, HeimBiotek Inc. has pioneered proprietary detection and analysis technology for microRNA, a small non-coding RNA, that is gaining recognition as a Next-Gen Diagnostic Tool. This state-of-the-art technology is being applied to develop diagnostic technology for disease detection utilizing circulating microRNA. We aim to harness this technology to develop liquid biopsy diagnostic kits, poised to revolutionize the future of molecular diagnostics.
Recently, the development of a liquid biopsy diagnostic kit for hepatocellular carcinoma has been completed successfully. Looking ahead, we aspire to introduce a Multi-Cancer Early Detection product capable of detecting 35 cancers simultaneously. In addition, steps are being taken to develop innovative PCR technology with high accuracy and sensitivity to establish a pipeline of products that address the unmet needs in the field of molecular diagnostics.​

HeimBiotek Inc. aims to be a premier provider of molecular diagnostic technology for cancer diagnostics. Our mission is to establish ourselves as a global leader in the field of cancer diagnostics through continued R&D and commercialization efforts. We are dedicated to improving global health and enhancing the quality of life for all.

CEO J.H. Lee

2.

Our History

"The Path of Achievements"

Company
Tech & Product
R&D Programs
Company.
History
2014
· HeimBiotek Est.
2015
· R&D Dept. Est.
· Venture Business Certification
2016
· HQ Relocation (Pangyo Silicon Park)
· ISO13485 Certification
2019
· EN ISO13485:2016 Certification
· Registration of
Pharmaceutical Manufacturing Facilities
2021
· KGMP Certification
Edit Template
Technology.
Product.
History
2015
· HB SBDE™ Technology R&D
(Specific Bi Directional Extension)
2015
· HB miRDx™ Technology R&D
miRNA Detection & Analysis
Real-time qPCR based
2017
· HB miR Multi Assay Kit™ Launch
miRNA Detection Kit RUO Products
2019
· Switching-PCR Technology R&D
Ultra-high Sensitive PCR
2019
· HB miRDx™ BKV Kit Launch
BKV Virus miRNA Detection
· HB miRDx™ EarlyHCC Kit
R&D commenced ​
2020
· 3C™ Technology R&D
Cross Contamination Check
2023 ~
· HB miRDx™ EarlyHCC Kit
Exploratory Clinical Trials (ECT) Complete
Confirmatory Clinical Trials (CCT) Complete
· HB miRDx™ EarlyLung Cancer Kit
· HB miRDx™ EarlyCRC Kit
· HB miRDx™ EarlyPancreatic Cancer Kit
Research Clinical Trials (RCT) Commenced
Edit Template
Goverment.
R&D Program.
History
2015
· Ministry of SMEs and Startups
Startup Growth - Technology Development Project
· the Ministry of Trade, Industry and Energy
Electronic Systems Specialized Technology Development Project - Advanced Medical Device Development Support Center
2016
· Ministry of SMEs and Startups
Demand-Specific Technology Development Project (Overseas Customers)
2018
· the Ministry of Health and Welfare
Investigator-Initiated Disease Conquest Research
2020 ~ 2021
· Ministry of SMEs and Startups
Technology Innovation Development Project for SMEs (Market Expansion Type)
BIG3 Innovation Startup Package
2021 ~ 2022
· the Ministry of Health and Welfare
Disease-Oriented Translational Research
Infectious Disease Prevention and Treatment Technology Development Project
Edit Template
(주)하임바이오텍
방문하신 것을 환영합니다.
현재 홈페이지 리뉴얼 작업 중입니다.
일부 페이지의 열람이 어려운 점 양해 바랍니다.
Do not see again